跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ANGISTOP 2 MG/ML + 0,5 MG/ML SOLUCION PARA PULVERIZACION BUCAL SABOR LIMON - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ANGISTOP 2 MG/ML + 0,5 MG/ML SOLUCION PARA PULVERIZACION BUCAL SABOR LIMON
Approved
STANDARD
ANGISTOP 2 MG/ML + 0,5 MG/ML SOLUCION PARA PULVERIZACION BUCAL SABOR LIMON
Laboratorios Vicks S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 28, 2025
Approval ID
235989fa965aa750
Company
Laboratorios Vicks S.L.
Type
Standard
Approval Details
Approval Id
235989fa965aa750
Drug Cima Aemps Name
ANGISTOP 2 MG/ML + 0,5 MG/ML SOLUCION PARA PULVERIZACION BUCAL SABOR LIMON
Register Number
90244
Holder Company Name
Laboratorios Vicks S.L.
Marketing Company Name
Procter & Gamble Espana S.A.
Authorization Date
2025-05-28
Dosage Form
SOLUCIÓN PARA PULVERIZACIÓN BUCAL
Dose
2 mg/ml + 0,5 mg/ml
Route Of Administration
Vía bucal (buccal use)
Prescription Type
Sin Receta
Commercialized
No
Company Name
Laboratorios Vicks S.L.
Active Ingredients
CLORHEXIDINA DIGLUCONATO
2 mg/ml
LIDOCAINA HIDROCLORURO MONOHIDRATO
0,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 28, 2025
Approval ID
235989fa965aa750
Type
Standard
Back to CIMA-AEMPS Approvals